Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Feb 28;12(8):1255-60.
doi: 10.3748/wjg.v12.i8.1255.

Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance

Antje Knöll  1 , Arndt Hartmann, Harald Hamoshi, Karin Weislmaier, Wolfgang Jilg
Affiliations

Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance

Antje Knöll et al. World J Gastroenterol. .

Abstract

Aim: To investigate the prevalence and clinical significance of "anti-HBc alone" in an unselected population of patients and employees of a university hospital in southern Germany.

Methods: All individuals with the pattern "anti-HBc alone" were registered over a time span of 82 mo. HBV-DNA was measured in serum and liver samples, and clinical charts were reviewed.

Results: Five hundred and fifty two individuals were "anti-HBc alone" (of 3004 anti-HBc positive individuals; 18.4%), and this pattern affected males (20.5%) more often than females (15.3%; P<0.001). HBV-DNA was detected in serum of 44 of 545 "anti-HBc alone" individuals (8.1%), and in paraffin embedded liver tissue in 16 of 39 patients tested (41.0%). There was no association between the detection of HBV genomes and the presence of biochemical, ultrasonic or histological signs of liver damage. Thirty-eight "anti-HBc alone" patients with cirrhosis or primary liver carcinoma had at least one additional risk factor. HCV-coinfection was present in 20.4% of all individuals with "anti-HBc alone" and was the only factor associated with a worse clinical outcome.

Conclusion: In an HBV low prevalence area, no evidence is found that HBV alone causes severe liver damage in individuals with "anti-HBc alone". Recommendations for the management of these individuals are given.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of HBV markers in 2986 anti-HBc positive individuals of different age groups, all referred to one virological laboratory over a period of 82 mo.
Figure 2
Figure 2
Percentage of HBV-DNA positive individuals (in serum) of all “anti-HBc alone” reactive individuals of different age groups.
See this image and copyright information in PMC

References

    1. Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Günther S, Hess G, Hüdig H, Kitchen A, Margolis H, et al. Serological pattern "anti-HBc alone": report on a workshop. J Med Virol. 2000;62:450–455. - PubMed
    1. Jilg W, Hottenträger B, Weinberger K, Schlottmann K, Frick E, Holstege A, Schölmerich J, Palitzsch KD. Prevalence of markers of hepatitis B in the adult German population. J Med Virol. 2001;63:96–102. - PubMed
    1. Knöll A, Stoehr R, Jilg W, Hartmann A. Low frequency of human polyomavirus BKV and JCV DNA in urothelial carcinomas of the renal pelvis and renal cell carcinomas. Oncol Rep. 2003;10:487–491. - PubMed
    1. Weinberger KM, Wiedenmann E, Böhm S, Jilg W. Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR) J Virol Methods. 2000;85:75–82. - PubMed
    1. Knöll A, Boehm S, Hahn J, Holler E, Jilg W. Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2004;33:925–929. - PubMed

Publication types

MeSH terms